JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lum, B. K. B.
Right arrow Articles by Nickerson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lum, B. K. B.
Right arrow Articles by Nickerson, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 116, Issue 2, 156-163, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


CARDIAC ARRHYTHMIAS INDUCED BY TOLAZOLINE (PRISCOLINE)

Bert K. B. Lum 1 and Mark Nickerson 1

1 Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan

The intravenous administration of tolazoline (Priscoline) induced cardiac arrhythmias, particularly ventricular premature contractions and ventricular tachycardia, in a high percentage of dogs anesthetized with cyclopropane, but not in those anesthetized with pentobarbital. Two dogs under cyclopropane anesthesia died of ventricular fibrillation following the administration of tolazoline.

Small doses of tolazoline (2.5 and 5.0 mgm.kgm.) produced arrhythmias of longer duration, and a more prolonged rise in blood pressure than did larger doses (10 and 20 mgm. kgm.).

Arrhythmias were produced predominantly after initial injections of tolazoline and were associated with a rise in blood pressure. Subsequent injections usually produced a fall in blood pressure and no arrhythmias. However, second small injections did produce serious arrhythmias when given concomitantly with mechanical elevation of the blood pressure. Elevation of the blood pressure did not allow repeated large doses to produce arrhythmias.

It is concluded that arrhythmias produced by tolazoline and by sympathomimetic amines are comparable in that they involve both a rise in blood pressure and a direct action on the myocardium, are facilitated by cyclopropane, and can be inhibited by a direct effect of large doses of tolazoline on the myocardium.

A considerable central nervous system stimulation following tolazoline administration was demonstrated in dogs anesthetized with cyclopropane or pentobarbital.

Submitted on August 25, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.